tetradecanoylphorbol acetate and carubicin

tetradecanoylphorbol acetate has been researched along with carubicin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujiwara, Y; Kasahara, K; Kubo, S; Niitani, H; Nishio, K; Saijo, N; Sugimoto, Y; Takeda, Y	1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and carubicin

Article	Year
Establishment of a human leukemia subline resistant to the growth-inhibitory effect of 12-O-tetradecanoylphorbol 13-acetate (TPA) and showing non-P-glycoprotein-mediated multi-drug resistance. International journal of cancer, 1991, Jul-30, Volume: 48, Issue:6 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carubicin; Cell Division; Cell Line; Cell Survival; Doxorubicin; Drug Resistance; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Glycoproteins; Subcellular Fractions; Tetradecanoylphorbol Acetate	1991

Article

Year

Establishment of a human leukemia subline resistant to the growth-inhibitory effect of 12-O-tetradecanoylphorbol 13-acetate (TPA) and showing non-P-glycoprotein-mediated multi-drug resistance.

International journal of cancer, 1991, Jul-30, Volume: 48, Issue:6

Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carubicin; Cell Division; Cell Line; Cell Survival; Doxorubicin; Drug Resistance; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Glycoproteins; Subcellular Fractions; Tetradecanoylphorbol Acetate

1991